GO:1904704 positive regulation of protein localization to adherens junction: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904704 describes any process that increases the frequency, rate or extent of protein localization to adherens junctions, which are cell-cell junctions built from cadherin-catenin complexes linked to actin filaments.
• Adherens junction assembly depends on E-cadherin, p120-catenin, beta-catenin, alpha-catenin, nectin and afadin, and on regulators such as Rho-family GTPases, Abl kinases and KIBRA.
• Dysregulated adherens junction protein localization contributes to cancer progression, including lobular breast cancer with E-cadherin to P-cadherin switching and colorectal cancer differentiation defects.
• MicroRNAs and endocytic pathways, such as Rab5a-dependent endocytosis, can destabilize junction proteins and thereby oppose positive regulation of protein localization to adherens junctions.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate regulators of adherens junction protein localization.
• EDITGENE provides end-to-end CRISPR cell model generation, library screening and bioinformatics to dissect GO:1904704-related mechanisms.
Description
GO:1904704, positive regulation of protein localization to adherens junction, is a biological process term that captures any activity that increases the delivery, retention or accumulation of proteins at adherens junctions. Adherens junctions are cell-cell adhesion structures composed of the epithelial cadherin-catenin complex, where the cytoplasmic face of the plasma membrane is connected to actin filaments. This process is fundamental for tissue architecture, barrier function and mechanical coupling between cells, and its disruption is linked to cancer, developmental defects and impaired wound healing. Researchers study GO:1904704 to understand how cells build and remodel junctions, how signaling pathways control cadherin and catenin trafficking, and how junctional protein mislocalization drives disease. Key regulators include Rho-family GTPases and their GAPs, Abl tyrosine kinases, KIBRA, folliculin and nectin-afadin complexes. Because adherens junction stability is dynamically controlled by endocytosis, cytoskeletal coupling and transcriptional programs, positive regulation of protein localization to adherens junctions sits at the intersection of cell adhesion, polarity and signaling.
positive regulation of protein localization to adherens junction At A Glance
| GO ID | GO:1904704 |
|---|---|
| GO term | positive regulation of protein localization to adherens junction |
| Ontology | biological_process |
| Synonym | activation of protein localization to cell-cell adherens junction; upregulation of protein localization in cell-cell adherens junction; positive regulation of protein localisation to cell-cell adherens junction |
| Major function | Increases the frequency, rate or extent of protein localization to adherens junctions, supporting cadherin-catenin complex assembly and actin-linked cell-cell adhesion. |
| Related cellular structure | Adherens junction, composed of the epithelial cadherin-catenin complex attached to actin filaments. |
| Representative regulators | KIBRA, folliculin, DLC3, Abl kinases, KCNQ1, nectin and Rab5a-dependent endocytosis components. |
| Disease relevance | Cancer progression, lobular breast cancer, colorectal cancer differentiation and endothelial junction dysfunction. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, imaging, proteomics and CRISPR library screening. |
What Is GO:1904704?
GO:1904704 is defined as any process that activates or increases the frequency, rate or extent of protein localization to adherens junction. An adherens junction is a cell-cell junction composed of the epithelial cadherin-catenin complex at which the cytoplasmic face of the plasma membrane is attached to actin filaments. In practice, this term covers molecular events that promote the arrival, stabilization or accumulation of junctional proteins such as cadherins, catenins, nectins and associated cytoskeletal linkers at sites of cell-cell contact.
Why Is positive regulation of protein localization to adherens junction Important in Cell Biology?
Positive regulation of protein localization to adherens junctions is important because adherens junctions are essential for tissue integrity, cell polarity and signaling, and their protein composition must be tightly controlled. When this process is perturbed, cells lose normal adhesion, which can promote invasion, metastasis and defective differentiation. Studies of KIBRA, folliculin, DLC3, Abl kinases, KCNQ1 and nectin have shown that junctional protein localization is actively regulated and that its disruption has direct disease consequences. Understanding GO:1904704 therefore provides mechanistic insight into cancer, tissue morphogenesis and barrier function, and it identifies candidate targets for therapeutic intervention.
• Maintains epithelial tissue architecture by ensuring cadherin-catenin complexes assemble at cell-cell contacts.
• Supports mechanical coupling of adherens junctions to the actin cytoskeleton through alpha-catenin and associated proteins.
• Regulates cell differentiation, as shown by KCNQ1:beta-catenin interaction driving colorectal cancer cell differentiation.
• Controls endothelial junction stability, with microRNAs regulating junction proteins and clinical consequences.
• Is opposed by endocytic removal of junction components, such as Rab5a-dependent nectin endocytosis.
• Is modulated by Rho-family GTPase signaling and GAP proteins such as DLC3.
• Is influenced by tyrosine kinase pathways, including Abl kinases that modulate cadherin-dependent adhesion.
• Is linked to tumor suppressor networks through KIBRA and Hippo signaling.
• Is relevant to Birt-Hogg-Dube syndrome biology via folliculin interaction with p0071 at adherens junctions.
• Provides a mechanistic framework for CRISPR-based target discovery in adhesion and cancer research.
What Happens During positive regulation of protein localization to adherens junction?
Initiation at cell-cell contact sites
In simple terms: Cells first touch and start gathering adhesion proteins at the contact point.
Positive regulation of protein localization to adherens junctions begins when cells establish initial contacts and recruit cadherin-catenin complexes to the plasma membrane. Nectin-based adhesion contributes to early junction formation, and nectin stabilization at adherens junctions is counteracted by Rab5a-dependent endocytosis, meaning that positive regulation must overcome endocytic removal to accumulate junction proteins. KIBRA connects Hippo signaling to cancer and influences junction-related processes, linking contact initiation to signaling control.
Cadherin-catenin complex assembly
In simple terms: Cadherins and catenins lock together to form the core of the junction.
The adherens junction core is the epithelial cadherin-catenin complex, and its assembly requires coordinated localization of E-cadherin, p120-catenin, beta-catenin and alpha-catenin. Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion, showing that accessory proteins control complex assembly. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements demonstrates that cadherin identity and localization are clinically relevant.
Cytoskeletal coupling and actin linkage
In simple terms: The junction is tied to the cell's internal skeleton so it can bear mechanical force.
Adherens junctions attach the cytoplasmic face of the plasma membrane to actin filaments, and this linkage depends on proteins such as alpha-catenin and associated actin regulators. Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases, providing a mechanism by which cytoskeletal signaling feeds back on junction protein localization. Spatial Rho regulation by the GAP protein DLC3 further illustrates how localized GTPase activity controls junction-associated actin dynamics.
Signaling control by GTPases and kinases
In simple terms: Small signaling switches and enzymes tell the junction where and when to add proteins.
Rho-family GTPases and their regulators are central to positive regulation of protein localization to adherens junctions. DLC3 is a GAP protein whose spatial regulation controls Rho signaling, and this in turn influences junction assembly and actin organization. Abl kinases act both upstream and downstream of Rho family GTPases to modulate cadherin-dependent adhesion, creating feedback loops that tune junction protein accumulation. KIBRA links Hippo signaling to cancer, connecting junctional regulation to growth-control pathways.
Stabilization versus endocytic removal
In simple terms: Proteins must be kept at the junction and prevented from being pulled back inside the cell.
Positive regulation of protein localization to adherens junctions requires a balance between delivery and removal. Nectin stabilization at adherens junctions is counteracted by Rab5a-dependent endocytosis, so factors that inhibit endocytosis or promote retention increase junctional protein levels. MicroRNA regulation of endothelial junction proteins shows that post-transcriptional control also affects the pool of proteins available for localization. Together, these mechanisms determine steady-state junction composition.
Integration with differentiation and disease programs
In simple terms: Junction protein placement is wired into larger cell fate decisions.
Adherens junction protein localization is not isolated from cell fate; bidirectional KCNQ1:beta-catenin interaction drives colorectal cancer cell differentiation, showing that junctional beta-catenin participates in differentiation signaling. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements further demonstrates that changes in cadherin localization accompany tumor phenotype. These examples show that GO:1904704 is embedded in developmental and oncogenic programs.
Key Genes Involved in GO:1904704 positive regulation of protein localization to adherens junction
The following genes and proteins have been experimentally linked to adherens junction protein localization and its positive regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KIBRA | Connects Hippo signaling to cancer and junction-related processes | Links junction regulation to growth-control pathways |
| FLCN | Folliculin interacts with p0071 to regulate cell-cell adhesion | Tumor suppressor relevant to Birt-Hogg-Dube syndrome |
| DLC3 | Rho GAP controlling spatial Rho regulation | Regulates junction-associated actin dynamics |
| ABL1 | Abl tyrosine kinase modulating cadherin-dependent adhesion | Acts upstream and downstream of Rho GTPases |
| ABL2 | Abl family kinase modulating cadherin-dependent adhesion | Contributes to adhesion regulation |
| KCNQ1 | Potassium channel with bidirectional interaction with beta-catenin | Drives colorectal cancer cell differentiation |
| CTNNB1 | Beta-catenin, core adherens junction and signaling protein | Central to junction assembly and differentiation |
| CDH1 | E-cadherin, core adherens junction cadherin | Cadherin switching in lobular breast cancer |
| CDH3 | P-cadherin, cadherin family member | E-cadherin to P-cadherin switching in breast cancer |
| PVRL1 | Nectin, early adherens junction adhesion molecule | Nectin stabilization counteracted by Rab5a endocytosis |
| RAB5A | Endocytic GTPase controlling nectin removal | Opposes junction protein stabilization |
| CTNND1 | p120-catenin, cadherin stability regulator | Part of the cadherin-catenin complex |
| CTNNA1 | Alpha-catenin, links cadherin complex to actin | Cytoskeletal coupling at adherens junctions |
| AFDN | Afadin, nectin-afadin junction organizer | Nectin-based junction assembly |
| RHOA | Rho GTPase controlling actin and junction assembly | Regulated by DLC3 and Abl kinases |
| MIRNAs | MicroRNAs regulating endothelial junction proteins | Post-transcriptional control of junction composition |
How Is positive regulation of protein localization to adherens junction Regulated?
Positive regulation of protein localization to adherens junctions is controlled at multiple levels. Rho-family GTPases and their GAP proteins, such as DLC3, provide spatial control of actin dynamics and junction assembly. Abl tyrosine kinases modulate cadherin-dependent adhesion both upstream and downstream of Rho family GTPases, creating feedback regulation. KIBRA links Hippo signaling to cancer and influences junction-related processes, connecting junctional regulation to growth-control pathways. Endocytic removal by Rab5a counteracts nectin stabilization, so positive regulation requires either enhanced delivery or reduced endocytosis. MicroRNAs add a post-transcriptional layer by regulating endothelial junction protein levels. Together, these mechanisms ensure that adherens junction composition is dynamic and responsive to cellular signals.
positive regulation of protein localization to adherens junction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FLCN | Birt-Hogg-Dube syndrome and cell-cell adhesion defects | FLCN knockout or point-mutation epithelial cell lines |
| CDH1 | Lobular breast cancer with cadherin switching | E-cadherin to P-cadherin knock-in breast cancer models |
| KCNQ1 | Colorectal cancer differentiation | KCNQ1 overexpression or knockout colorectal cells |
| KIBRA | Cancer and Hippo signaling dysregulation | KIBRA knockout or tagged knock-in cancer cell lines |
| RAB5A | Endothelial and epithelial junction destabilization | RAB5A point-mutation or knockout junction models |
Cancer progression and metastasis
Disruption of adherens junction protein localization is a hallmark of cancer progression. KIBRA connects Hippo signaling and cancer, implicating junction-associated signaling in tumorigenesis. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements shows that cadherin identity changes accompany tumor phenotype. Bidirectional KCNQ1:beta-catenin interaction drives colorectal cancer cell differentiation, linking junctional beta-catenin to differentiation control. These findings suggest that positive regulation of protein localization to adherens junctions can either restrain or promote tumor behavior depending on context.
Birt-Hogg-Dube syndrome and tumor suppressor biology
Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion. This directly connects a hereditary cancer syndrome to adherens junction protein localization, suggesting that loss of folliculin function may perturb junction assembly and contribute to disease.
Endothelial junction dysfunction
MicroRNA regulation of endothelial junction proteins has clinical consequences, indicating that post-transcriptional control of adherens junction composition affects vascular barrier function. Nectin stabilization at adherens junctions is counteracted by Rab5a-dependent endocytosis, providing a mechanism by which endothelial junctions can be destabilized.
From positive regulation of protein localization to adherens junction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce adherens junction protein localization? | CRISPR knockout cell line followed by imaging and proteomics |
| Does a specific phosphorylation site control junction protein recruitment? | CRISPR point-mutation knock-in of the phospho-site |
| Does a disease-associated variant alter junction assembly? | CRISPR knock-in of the patient variant |
| Where and when does a regulator localize at junctions? | Endogenous tagged knock-in with fluorescent tag |
| Does overexpression of a regulator increase junction protein accumulation? | CRISPR overexpression or cDNA overexpression cell model |
| Which genes regulate adherens junction protein localization genome-wide? | CRISPR library screening with junction-based readout |
How to Study the positive regulation of protein localization to adherens junction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Localization and intensity of junction proteins | Validating positive regulation of protein localization |
| Live-cell imaging | Dynamics of tagged junction proteins | Tracking junction assembly and remodeling |
| Affinity purification mass spectrometry | Protein-protein interactions at junctions | Identifying regulators such as folliculin-p0071 |
| CRISPR knockout screening | Genes required for junction protein localization | Genome-wide discovery of positive regulators |
| RNA-seq | Transcriptional changes in junction-related genes | Linking signaling to junction composition |
| MicroRNA profiling | Post-transcriptional regulators of junction proteins | Endothelial junction regulation |
| Phosphoproteomics | Signaling events controlling junction assembly | Mapping kinase pathways such as Abl |
| Proximity labeling | Spatial proteome of adherens junctions | Defining junction-associated protein networks |
Imaging-based junction assays
Fluorescence microscopy of junction proteins such as E-cadherin, beta-catenin and nectin allows direct measurement of protein localization to adherens junctions. Tagged knock-in cell lines enable live-cell imaging of junction dynamics. These approaches are essential for validating positive regulation of protein localization to adherens junctions.
Proteomics and interactomics
Affinity purification and mass spectrometry can identify proteins that localize to adherens junctions and their interaction partners. Folliculin interaction with p0071 was identified through such approaches, demonstrating the value of proteomics for this process. Quantitative proteomics can also measure changes in junction composition after genetic perturbation.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens with junction protein localization as a readout can identify positive regulators. This approach is powerful for discovering new components of GO:1904704 and for linking them to disease pathways.
Transcriptional and post-transcriptional profiling
RNA-seq and microRNA profiling reveal how junction protein levels are controlled transcriptionally and post-transcriptionally. MicroRNA regulation of endothelial junction proteins illustrates the importance of this layer. Integrating these data with imaging and proteomics provides a systems view of junction regulation.
How CRISPR Can Be Used to Study GO:1904704 positive regulation of protein localization to adherens junction
Knockout
CRISPR knockout of candidate genes such as FLCN, KIBRA, RAB5A or DLC3 can test whether they are required for positive regulation of protein localization to adherens junctions. Knockout cells can be analyzed by imaging and proteomics to quantify junction protein accumulation.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to test the role of phosphorylation or catalytic sites in regulators of adherens junction protein localization. For example, mutating Rho GAP catalytic residues in DLC3 or kinase domains in Abl family members can reveal mechanism.
Knock-in
CRISPR knock-in of fluorescent or epitope tags at endogenous loci enables tracking of junction proteins such as E-cadherin, beta-catenin or nectin in live cells. Knock-in of disease-associated variants, such as those in FLCN or CDH1, can model patient-specific effects on junction assembly.
Overexpression
CRISPR activation or cDNA overexpression of candidate positive regulators can test whether increased dosage enhances protein localization to adherens junctions. Overexpression of KCNQ1 or beta-catenin can modulate differentiation and junction composition in colorectal cancer models.
How EDITGENE Supports positive regulation of protein localization to adherens junction Research
Researchers studying positive regulation of protein localization to adherens junction-related genes often need to determine whether a candidate gene is causally involved in junction assembly, stabilization or disease-associated mislocalization. EDITGENE provides the CRISPR cell models and screening services required to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein localization to adherens junction research.
Frequently Asked Questions About positive regulation of protein localization to adherens junction
What is GO:1904704?
GO:1904704 is the Gene Ontology term for positive regulation of protein localization to adherens junction, meaning any process that increases the frequency, rate or extent of protein localization to adherens junctions, which are cadherin-catenin complexes linked to actin filaments.
What is positive regulation of protein localization to adherens junction?
It is the biological process that promotes the delivery, retention or accumulation of proteins at adherens junctions, supporting cell-cell adhesion and cytoskeletal coupling.
What genes are involved in positive regulation of protein localization to adherens junction?
Key genes include FLCN, KIBRA, DLC3, ABL1, ABL2, KCNQ1, CTNNB1, CDH1, CDH3, PVRL1, RAB5A, CTNND1, CTNNA1, AFDN and RHOA.
How is adherens junction protein localization regulated?
It is regulated by Rho-family GTPases and GAP proteins such as DLC3, Abl tyrosine kinases, KIBRA-Hippo signaling, endocytic removal by Rab5a and microRNAs.
Why is adherens junction protein localization important in cancer?
Disrupted junction protein localization is linked to cancer progression, including lobular breast cancer with cadherin switching and colorectal cancer differentiation defects.
What diseases are associated with GO:1904704 dysfunction?
Diseases include Birt-Hogg-Dube syndrome through folliculin, lobular breast cancer through cadherin switching, colorectal cancer through KCNQ1:beta-catenin signaling and endothelial barrier dysfunction.
How can I study positive regulation of protein localization to adherens junction?
You can use fluorescence imaging, proteomics, RNA-seq, microRNA profiling and CRISPR screens to measure junction protein localization and identify regulators.
What CRISPR models are useful for studying adherens junction regulation?
Knockout, point-mutation, knock-in, tagged knock-in and overexpression models are all useful for testing causal roles of candidate genes in GO:1904704.
Which proteins form the adherens junction core?
The core is the epithelial cadherin-catenin complex, including E-cadherin, p120-catenin, beta-catenin and alpha-catenin, linked to actin filaments.
How does EDITGENE support adherens junction research?
EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening and bioinformatics to dissect positive regulation of protein localization to adherens junctions.
Conclusion
GO:1904704, positive regulation of protein localization to adherens junction, is a central biological process that controls how cells assemble and maintain cadherin-catenin complexes at cell-cell contacts. Its regulation by Rho GTPases, Abl kinases, KIBRA, folliculin, KCNQ1, nectin and endocytic pathways places it at the crossroads of adhesion, signaling and disease. Dysregulation of this process contributes to cancer and other pathologies, making it an important area for mechanistic and translational research. CRISPR-based cell models and screening approaches offer powerful tools to identify and validate the regulators that drive this process.
References
- 1. Swaroop B SS et al.. 2021. KIBRA connects Hippo signaling and cancer.. Exp Cell Res 403(2):112613 PMID: 33901448
- 2. Zhuang Y et al.. 2016. MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence.. Mediators Inflamm 2016:5078627 PMID: 27999452
- 3. Medvetz DA et al.. 2012. Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion.. PLoS One 7(11):e47842 PMID: 23139756
- 4. Hendrick J et al.. 2019. Spatial Rho regulation: Molecular mechanisms controlling the GAP protein DLC3.. Small GTPases 10(1):13-19 PMID: 27849131
- 5. Rapetti-Mauss R et al.. 2017. Bidirectional KCNQ1:β-catenin interaction drives colorectal cancer cell differentiation.. Proc Natl Acad Sci U S A 114(16):4159-4164 PMID: 28373572
- 6. Christgen M et al.. 2020. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements.. Mod Pathol 33(12):2483-2498 PMID: 32572153
- 7. Zandy NL et al.. 2008. Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases.. Cell Cycle 7(4):444-8 PMID: 18235247
- 8. Cervero P et al.. 2021. Nectin stabilization at adherens junctions is counteracted by Rab5a-dependent endocytosis.. Eur J Cell Biol 100(7-8):151184 PMID: 34826799
